Document is current
Any future updates will be listed below
-
Authors
Finda, Marceline F. http://orcid.org/0000-0003-4460-4415
Christofides, Nicola
Lezaun, Javier
Tarimo, Brian
Chaki, Prosper
Kelly, Ann H.
Kapologwe, Ntuli
Kazyoba, Paul
Emidi, Basiliana
Okumu, Fredros O.
-
Funding
Funding for this research was provided by:
Consortium for Advanced Research Training in Africa (087547/Z/08/Z)
Howard Hughes Medical Institute (OPP1099295)
Bill and Melinda Gates Foundation (OPP1177156)
Application of Novel Transgenic technology & Inherited Symbionts to Vector Control (AVPP0027/1)
- License Information
-
More Information
Article History
Received: 18 December 2019
Accepted: 16 April 2020
First Online: 23 April 2020
Ethics approval and consent to participate
: This study is nested as a public engagement component under two larger studies at Ifakara Health Institute titled “<i>Anopheles funestus gene flow studies and rearing methods</i>” and <i>“Demonstrating complete disruption of residual malaria transmission by eliminating Anopheles funestus mosquitoes from Tanzanian villages”.</i> Ethical approvals for this project were obtained from Ifakara Health Institute’s Institutional Review Board (Protocol ID: IHI/IRB/EXT/No: 007 - 2018) and the Medical Research Coordinating Committee at the National Institute for Medical Research, in Tanzania (Protocol ID: NIMR/HQ/R.8a/Vol.IX/2895), as well as the University of the Witwatersrand in South Africa (Clearance certificate No. M180820). Meetings were held with leaders of each stakeholder groups to request their consent to conduct this study prior to the recruitment of participants. Upon consent, formal letters were sent to each of the participants to invite them to the discussions. Written consents were also sought from all participants of this study, after they had understood the purpose and procedure of the discussions.
: Permission to publish this study was obtained from NIMR (Ref: NIMR/HQ/P.12 VOL XXIX/37).
: The authors declare that they have no competing interests.
